Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer

Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer

Risk-stratified pathways (RSPs) are recommended by the European Association of Uro-logy (EAU) to improve the early detection of clinically significant prostate cancer (csPCa). RSPs can reduce magnetic resonance imaging (MRI) demand, prostate biopsies, and the over-detection of insignificant PCa (iPC...

Full description

Bibliographic Details
Main Authors: Juan Morote, Ángel Borque-Fernando, Luis M. Esteban, Ana Celma, Miriam Campistol, Berta Miró, Olga Méndez, Enrique Trilla
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Personalized Medicine
Subjects:
screening
prostate cancer
Barcelona risk calculator
Proclarix
risk-stratified pathway
Online Access:https://www.mdpi.com/2075-4426/14/2/130

Internet

https://www.mdpi.com/2075-4426/14/2/130

Similar Items